Hosted on MSN
Why 10x Genomics Stock Was Sliding This Week
Gene sequencing technology company 10x Genomics (NASDAQ: TXG) hasn't been having it easy in the past few days on the stock market. A bearish analyst move dampened sentiment on the company, and ...
Learn more about whether Tempus AI, Inc. or 10x Genomics, Inc. is a better investment based on AAII's A+ Investor grades, ...
Biotech company 10x Genomics (NASDAQ:TXG) reported Q3 CY2025 results , but sales fell by 1.7% year on year to $149 million. On top of that, next quarter’s revenue guidance ($156 million at the ...
Investors usually find it discouraging when an analyst cuts the price target on one of their stocks. In this instance, the cut to this company's shares was rather deep. It wasn't immediately apparent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results